First Live Birth After Fertility Preservation Using Vitrification of Oocytes in a Woman with Mosaic Turner Syndrome
Overview
Reproductive Medicine
Authors
Affiliations
Purpose: To report the case of a young woman diagnosed with Turner syndrome (TS) who achieved a live birth using her own oocytes that had been vitrified for fertility preservation.
Methods: A 25-year-old woman with mosaic (45,X/46,XX) TS was referred for fertility preservation (FP) counseling. Serum anti-Müllerian hormone (AMH) level was normal (6.4 µg/L). In view of the unpredictable rate of follicle loss in TS individuals, she requested FP and underwent two cycles of ovarian stimulation (OS) for oocyte cryopreservation (OoC) using a GnRH antagonist protocol and recombinant follicle stimulating hormone (rFSH), 200-250 IU daily for 8 resp. 12 days.
Results: In total, 29 metaphase II oocytes (MII) were vitrified after OS. After conceiving spontaneously and achieving a live birth, she returned to the clinic five years after OoC with a desire for pregnancy using in vitro fertilization (IVF) of her cryopreserved oocytes and preimplantation genetic testing (PGT-A). All 29 MII oocytes were thawed; 23 oocytes survived (79.3%) and were inseminated with partner sperm using intracytoplasmic sperm injection (ICSI). Thirteen oocytes were fertilized resulting in three good quality blastocysts which were vitrified after trophectoderm biopsy for PGT-A using array-CGH. Two blastocysts were found to be euploid. One was thawed and transferred to the uterus using a HRT priming protocol. An uneventful pregnancy occurred. The patient delivered a healthy baby girl weighing 3490 g at 40 weeks of gestation.
Conclusions: We report the first live birth achieved using cryopreserved oocytes in a woman diagnosed with mosaic TS. Cryopreservation of oocytes after ovarian stimulation is a realistic option for FP in selected post menarche individuals with mosaic TS. Whether PGT-A may reduce the risk of pregnancy loss in TS has to be confirmed by further studies.
Luo Y, Liao X, Wen J, Wu W, Tang G, Zhu H J Assist Reprod Genet. 2025; .
PMID: 39903408 DOI: 10.1007/s10815-025-03394-9.
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt C, Andersen N, Christin-Maitre S, Davis S, Duijnhouwer A, Gawlik A Eur J Endocrinol. 2024; 190(6):G53-G151.
PMID: 38748847 PMC: 11759048. DOI: 10.1093/ejendo/lvae050.
Navigating fertility dilemmas across the lifespan in girls with Turner syndrome-a scoping review.
van der Coelen S, van der Velden J, Nadesapillai S, Braat D, Peek R, Fleischer K Hum Reprod Update. 2024; 30(4):383-409.
PMID: 38452347 PMC: 11215162. DOI: 10.1093/humupd/dmae005.
Oocyte cryopreservation in mosaic Turner syndrome with polycystic ovaries.
Sienko A, Prakash A, MacDougall J F S Rep. 2024; 4(4):380-383.
PMID: 38204943 PMC: 10774874. DOI: 10.1016/j.xfre.2023.10.001.
Reproductive health in Turner's syndrome: from puberty to pregnancy.
Porcu E, Cipriani L, Damiano G Front Endocrinol (Lausanne). 2023; 14:1269009.
PMID: 38116311 PMC: 10728473. DOI: 10.3389/fendo.2023.1269009.